GlobalData analyst Shehroz Mahmood notes that Novo Nordisk's amycretin could become the "next frontier" in obesity and T2D.

While the Phase III results confirm prior analyst sentiments, a KOL notes that GLP-1RAs could still show potential in the ...

Nuvalent will discuss the data for TKI pre-treated ALK-positive NSCLC patients with the FDA in a pre-NDA meeting ...

Novartis’ RLT received US FDA approval for earlier use in mCRPC. Credit: Konektus Photo/Shutterstock. Novartis has reported topline outcomes from the Phase III PSMAddition trial’s pre-specified ...

The efficacy evaluable data set comprised 21 participants. Credit: NMK-Studio/Shutterstock.com. Synthekine has reported positive initial data from a Phase Ia/Ib trial evaluating STK-012 in first-line, ...

Contineum Therapeutics’ M1 antagonist, PIPE-307, has failed to meet its primary and secondary efficacy endpoints in a Phase II trial in RRMS. Image credit: Andrzej Rostek via ShutterStock.com.

The never-ending challenge of finding and recruiting eligible clinical trial participants continues to push sponsors to find new avenues to expedite enrolment. As decentralisation shakes up ...

There have been several impactful clinical trial read outs in 2024. Image credit: Shutterstock / Rajitha Tennakoon From gene therapies to psychedelics and cancer vaccines to HIV pre-exposure ...

It’s only been a month since the Ukraine war started, yet thousands of lives have been lost, millions have fled into neighbouring countries, and innumerable infrastructure destroyed. In terms of ...

The number of mergers and acquisitions (M&A) among contract research organisations (CROs) saw an uptick in 2021 despite the Covid-19 pandemic. Last year saw 50 completed M&A deals, increasing by 21 ...

China is an attractive study destination, yet our data-driven analysis shows the country’s clinical trial industry is still insular. Clinical Trials Arena maps the barricades. China’s increasing ...